International Journal of Clinical Case Reports 2015, Vol.5, No. 45, 1-6
6
Cassorla F., Mericq V., Eggers M., Avila A., Garcia C., Fuentes A., Rose
S.R., Gordon B., and Cutler J.R., 1997, Effects of luteinizing hormone-
releasing hormone analog-induced pubertal delay in growth hormone
(GH) deficient children treated with GH: preliminary results, J. Clin.
Endocrinol. Metab, 82: 3989-3992
Codner E., Mericq V., and Cassorla F., 1997, Optimizing growth hormone
therapy during puberty, Horm Res., 48(suppl5): 16-20
Coutant R., and Carel J.C., 2002, Le diagnostic du déficit en hormone de
croissance chez l’enfant, Mt Endocrinologie, 4(1), Hormone de croissance
Cutfield W., Lindberg A., Albertsson Wikland K., Chatelain P., Ranke M.B.,
and Wilton P., 1999, Final height in idiopathic growth hormone
deficiency: the kigs experience-kigs international board, Acta. Paediatr.
Suppl., 88(428): 72-75
Daftary S.S., and Gore A.C., 2005, IGF-1 in the brain as a regulator of
reproductive neuroendocrine function, Experimental Biology and
Medicine, 203: 292-306
Frasier S.D., Costin G., Lippe B.M., Aceto T.J.R., and Bunger P.F., 1981, A
dose response curve for human growth hormone, J. Clin. Endorinol.
Metab., 53: 1213-1217
Frish H., and Birnbacher R., 1995, Final height and pubertal development in
children with growth hormone deficiency after long-term treatment,
Horm. Res., 43: 132-134
G.H research society, 2000, Consensus guidelines for the diagnosis and
treatment of growth hormone (GH) deficiency in childhood and
adolescence: summary statement of the GH research society, J. Clin.
Endocrinol. Metab, 85: 3990-3993
Hibi I., Tanaka T., Tanae A., Kagawa J., Hashimoto N., Yoshizaw A., and
Shizumek A., 1989, The influence of gonadal function and the effect of
gonadal suppression treatment on final height in growth hormone (GH)
treated GH-deficient children, J. Clin. Endocrinol. Metab., 69: 221-226
Job J., 1983, L’hormone de croissance, Rev. Franç. Endocrinol. Clin., 24:
4-5 (Juillet- Octobre)
Job J.C., and Pierson M., 1981, Hypophyse dans Endocrinologie Pédiatrique,
80-89
Job J.C., Maillard F., and Goujard J., 1992, Epidemiological survey of
patients treated with growth hormone in France in the periode 1959-1990
= preliminary results, Horm. Res., 38(Suppl. 1): 35-43
Kazerr R., Unter man T.G., and Glick R.P., 1990, An abnormality of the
growth hormone/ insulin like growth factor 1 axis in women with
polycystic ovary syndrome, J. Clin. Endocrinol. Metab, 71(4): 958-962
Kohn B., Julins J.R., and Blethen S.L., 1999, Combined use of growth
hormone and gonadotropin-releasing hormone analogues: the national
cooperative growth study experience, Pediatrics, 104: 1014-1017
Maiza E.H., 1983, Puberté de l’enfant en zone aride – hoggar (daira de
tamanrasset): résultats d’une enquête transversale, D.E.S.M en Médecine,
Directeur de Thèse Pr. KEDDARI. M
Marshall W.A., and Tanner J.M., 1970, Variations in the pattern of pubertal
changes in boys, Arch. Dis. Child, 45: 13-23
Mauras N., Rogol A.D., Haymond M.W., and Veldhuis J.D., 1996, Sex
steroïds, growth hormone, IGF1: neuro-endocrine and metabolic
regulation in puberty, Horm. Res., 45: 74- 80
Mericq M.V., Eggers M., Avila. A., Culter J.R.G.B., and Cassorla F., 2000,
Near final height in pubertal growth hormone (GH)-deficient patients
treated with GH alone or in combination with luteinizing
hormone-releasing hormone analog: results of a prospective, randomizd trial,
J. Clin. Endocrinol. Metab, 85: 569-573
Morales A.J., 1997, Role of growth hormone in polycistic ovarian syndrome,
Semin Repord Endocrinol., 15: 177-182
Perelman R., and Perelman S., 1994, La Croissance et ses troubles:
croissance anté-natale normale, Pédiatrie Pratique III. Maladies des
Glandes Endocrines, Paris: Maloine
Pienkowski C., Lamiche-Lorenzini F., Cartault A., Fazal Jifeigerl-Ova,
Lessourd F., and Tauber M., 2007, Les troubles de la fertilitédans les
affections endocriniennes, Archives de Pédiatrie, 14(6): 715-717
Pierson M., 1986, La maturation pubertaire, Croissance et développement
sexuel, aspects cliniques: Revue du Praticien, 36: 805-811
Price D.A., and Heidelberg J., 1999, GH testing in KIGS = the clinical
reality in: Ranke M.B., Wilton P., growth hormone therapy in KIDS –
10 years experience, AM Brosius Barth Verlog, 73-80
Saenger P., 2003, Dose effects of growth hormone during puberty,
Horm.
Res., 60(1): 52-57
Saggese G., Frederico G., Barsanti S., and Fiore L., 2001, The effect of
administering gonadotropin-releasing hormone agonist with
recombinant-human growth hormone (GH) on the final height of girls
with isolated GH deficiency: results from a controlled study, J. Clin.
Endocrinol. Metab, 86(5): 1900-1904
Sempe M., Pedron G., and Roy-pernot M.P., 1979, Auxologie méthode et
séquences, Laboratoires Théraplix . ED. Paris
Tanaka T., Cohen P., Clayton P.E., Laron Z., Hintz R.L., and Sizonenko P.C.,
2002, Diagnosis and management of growth hormone deficiency in
childhood and adolescence part 2 = growth hormone treatment in
growth hormone deficient children, Growth Hormone and IGF
Research, 12(5): 323-341
Tanner J.M., and Witehouse R.H., 1976, Clinical longtudinal standards for
height, height velocity, weight velocity and stages of puberty, Arch. Dis.
Child., 51(3): 170-179
Tobiume H., Kanzaki S., Hida S., Ono T., Moriwake T., Yamauchi S., Tanaka H.,
and Seino Y., 1997, Serum bone alkaline phosphatase isoenzyme levels in
normal children and children with growth hormone (GH) deficiency: a
potential marker for bone formation and response to GH therapy, J.
Clin. Endocrinol. Metab, 82(7): 2056-2061
Toublanc J.E., Couprie C., Garnier P., and Job J.C., 1989, The effect of
treatment combining an agonist of gonadotropin-releasing hormone
with growth hormone in pubertal patients with isolated growth
hormone deficiency, Acta. Endocrinol., 120: 795-799
Vimpani G.V., Vimpani A.F., Lidgard G.P., Cameron E.H.D., and Farquhar
J.W., 1977, Prevalence of severe growth hormone deficiency, BMJ,
2(60- 84): 427-430
